Cosentyx (secukinumab): Reviews and patient testimonials


/static/themes-v3/default/images/default/opinion/traitement/intro.jpg?1720004028

Back Back to the list of medications

Medication indications

Cosentyx 150 mg solution for injection in pre-filled syringe and pre-filled pen

Plaque psoriasis

Cosentyx is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy.

Psoriatic arthritis

Cosentyx, alone or in combination with methotrexate (MTX), is indicated for the treatment of active psoriatic arthritis in adult patients when the response to previous disease-modifying anti-rheumatic drug (DMARD) therapy has been inadequate.

Ankylosing spondylitis

Cosentyx is indicated for the treatment of active ankylosing spondylitis in adults who have responded inadequately to conventional therapy.


Route of administration: Injectable
Molecule: secukinumab

Patients' opinions on Cosentyx

In brief

General satisfaction level: 7.78/10 Learn more

Treatment's effectiveness: 7.56/10 Learn more

Ease of use: 9.67/10 Learn more

Adherence to prescription: 9.50/10 Learn more

Detected side effects: 6.89/10 Learn more

Improvement in the quality of life: 7.67/10 Learn more

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Never
10 = Always

1 = Not at all important
10 = Extremely important

1 = Not at all satisfied
10 = Extremely satisfied

Tips and advice of the community


avatar
Unregistered member
on 09/10/2021

Life Changer. Made my life more bearable. Thank you Cosentyx.

Your message

Conditions related to this medication

Fact sheet

Psoriasis

See the fact sheet
Fact sheet

Psoriatic arthritis

See the fact sheet
Fact sheet

Ankylosing spondylitis

See the fact sheet